{"id":5,"date":"2022-07-20T18:05:12","date_gmt":"2022-07-20T18:05:12","guid":{"rendered":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/?page_id=5"},"modified":"2026-04-15T10:38:26","modified_gmt":"2026-04-15T10:38:26","slug":"homepage","status":"publish","type":"page","link":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/","title":{"rendered":"Homepage"},"content":{"rendered":"
<\/div>\n \n PALYNZIQ\u00ae<\/sup> (pegvaliase-pqpz) Injection is the first and only FDA-approved therapy that can lower Phe levels in people aged 12 and up, across PKU types and regardless of diet.1-3<\/sup>*<\/p>\n See the data<\/a> <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\nPALYNZIQ is the first and only enzyme replacement therapy<\/span>
\nfor people with PKU1,4,5<\/sup><\/strong><\/h2>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n
\n\t Phe reduction in adolescents and adults1<\/sup>\n<\/h4>\n \n \n <\/div>\n